Posted on 5/17/18
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
RALEIGH, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced that it has entered into definitive agreements with existing institutional and . . .
Posted on 4/29/18
Pharmaceutical Industry Study Highlights the Evolving Role of Field-Based Medical Teams in Serving Managed Care Organizations
As the influence and importance of payers has grown in the United States, the pharmaceutical industry has turned to field medical teams to handle managed care . . .
Posted on 4/23/18
Cambrex Completes New $3.2 Million Analytical Research & Development Laboratory at its High Point, NC Facility
EAST RUTHERFORD, N.J., April 23, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today . . .
Posted on 4/20/18
ASAP Urgent Dental Care Planning Expansion to Raleigh, Charlotte and Fayetteville, NC
"ASAP Urgent Dental Care" is Planning to Add Locations in Raleigh, Charlotte and Fayetteville, NC. ASAP Urgent Dental Care is currently evaluating locations to bring Urgent . . .
Posted on 4/19/18
Argos Therapeutics Stock Falls 68% as it Terminates Drug Trial
Argos Therapeutics, Inc. reported it will terminate its study on treatment of newly diagnosed metastatic renal cell carcinoma, causing is stock to fall 68 percent on . . .
Posted on 4/10/18
VTV Therapeutics Shares Plunge Following Failure of Alzheimer’s Clinical Trial
VTV Therapeutics Inc. saw its stock price fall by more than 65 percent in after-market trading Monday after it disclosed disappointing results from the clinical trial . . .
Posted on 4/9/18
Aeterna Zentaris Files Management Information Circular
CHARLESTON, S.C., April 09, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) is pleased to announce that it has filed its Management Information Circular for . . .
Posted on 4/5/18
ReForm Biologics and KBI Biopharma Announce Strategic Partnership
CAMBRIDGE, Mass. & DURHAM, N.C.--(BUSINESS WIRE)--ReForm Biologics and KBI Biopharma, Inc., (KBI) today announced a strategic partnership to make improved biopharmaceutical formulations. Through this collaboration, KBI . . .
Posted on 3/28/18
Dova Fires Auditor KPMG, Hires Ernst & Young
Dova Pharmaceuticals Inc., based in Durham, North Carolina, dismissed accounting firm KPMG as its auditor on March 21 and replaced it with Ernst & Young, according . . .
Posted on 3/27/18
Fennec Pharmaceuticals Receives Breakthrough Therapy Designation by FDA for PEDMARK
RESEARCH TRIANGLE PARK, N.C., March 27, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX), a specialty pharmaceutical company, today announced that the U.S. Food and . . .
Posted on 3/27/18
Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution
RALEIGH, N.C. , March 27, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the company is a . . .
Posted on 3/26/18
NovaQuest Capital Management Acquires CutisPharma
CutisPharma, Inc., a specialty pharmaceutical company that for two decades has been the industry leader in providing innovative solutions to pharmacists, with its recently approved 505(b)(2) . . .
Posted on 3/25/18
Fennec Pharmaceuticals Granted Fast Track Designation From FDA
Fennec Pharmaceuticals Inc., a specialty drug company, announced it has been granted fast track designation for its signature drug by the U.S. Food and Drug Administration.Fast . . .
Posted on 3/23/18
BioDelivery’s Earnings Miss Expectations, But Revenue Beats Estimates
BioDelivery Sciences International Inc., a pharmaceutical company focusing on pain management and addiction medicine, reported a fourth-quarter loss that was worse than expected but reported revenue . . .
Posted on 3/19/18
Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma
DURHAM, N.C., March 19, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases . . .
Posted on 3/12/18
G1 Therapeutics Announces Closing of Offering of Common Stock
RESEARCH TRIANGLE PARK, N.C., March 12, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced the closing of an underwritten public . . .
Posted on 3/11/18
DeGen Medical Receives E3 MIS System FDA Clearance
Florence, S.C., March 09, 2018 (GLOBE NEWSWIRE) -- DeGen Medical announced the FDA clearance of E3 MIS™ Modular Pedicle Screw System for thoraco-lumbar spine. E3 MIS™system . . .
Posted on 3/8/18
G1 Therapeutics Announces Pricing of Offering of Common Stock
RESEARCH TRIANGLE PARK, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced the pricing of an underwritten public . . .
Posted on 3/8/18
Durham-based Argos Therapeutics Has Enough Cash To Last Through End Of 2018
Argos Therapeutics Inc., an immune-oncology company, has enough cash to to fund its operations through the end of 2018, according to a Securities and Exchange Commissions . . .
Posted on 3/6/18
PRA Health Sciences Named Best CRO in Asia
RALEIGH, N.C., March 06, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) is honored to once again be named Best CRO in Asia. PRA received . . .
Posted on 3/5/18
G1 Therapeutics Announces Proposed Offering of Common Stock
RESEARCH TRIANGLE PARK, N.C., March 05, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that it has commenced an underwritten . . .
Posted on 3/5/18
Raleigh-based Innovate Bio Stock Rises 54%, Hopes Celiac Disease Drug Is The First Of Many
Innovate Biopharmaceuticals Inc., which saw its stock price rise 54 percent on Friday, is focused on developing novel medicines for autoimmune and inflammatory diseases with unmet . . .
Posted on 2/25/18
Tenax Therapeutics Announces Reverse Stock Split
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on providing products to address conditions with significant unmet medical needs, today announced a . . .
Posted on 2/23/18
Dova Pharmaceuticals Prices Offering of Common Stock
DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases . . .
Posted on 2/21/18
Dova Pharmaceuticals Announces Proposed Offering of Common Stock
DURHAM, N.C., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases . . .
Charlotte Raleigh
